Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Παρασκευή 16 Μαρτίου 2018
The use of EGFR-CD3 bispecific antibody and antigen-specific high avidity T cells to target cancer associated fibroblasts and cancer cells within a melanoma organoid system
Publication date: March 2018 Source:European Journal of Cancer, Volume 92, Supplement 1 Author(s): N. Reddy, B. Chung, E. Chu, A. Esmaeili, T. Tu, P. Lee
from Cancer via ola Kala on Inoreader http://ift.tt/2pkJhKi via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου